课题基金 / 基金详情

Kenya Quality Model for Community Health: a unique model for quality improvement in Antenatal Care

Kenya Quality Model for Community Health: a unique model for quality improvement in Antenatal Care
肯尼亚社区健康质量模型:产前护理质量改进的独特模型
批准号:
MR/T003324/1
负责人:
Miriam Taegtmeyer
金额:
$19.32万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --

项目摘要

项目成果

Miriam Taegtmeyer的其他基金

相似基金

相关文献

中文摘要
翻译
在怀孕早期接受产前护理的比例很低,特别是在肯尼亚的农村人口和青少年中。所有孕妇都应该对可能对母亲或婴儿造成伤害的常见疾病进行测试,以便在怀孕期间尽早诊断和治疗这些疾病,最好是在怀孕20周之前。肯尼亚指南建议对艾滋病毒、梅毒、疟疾(如果发烧)和贫血进行检测。在实践中,只有艾滋病毒检测是始终如一的,即使这样做也可能延迟(有时检测呈阳性的妇女可能得不到及时的治疗)。其他检查往往完全被错过,因为来自农村地区的妇女负担不起去遥远设施的实验室的时间和金钱,并且由于服务质量差而被推迟在较低的设施(如药房)参加产前护理。所有这些问题加在一起,可能会导致母亲及其新生儿的妊娠结局不佳,特别是在这些弱势群体中。不需要训练有素的实验室人员的低成本技术可以在护理点进行快速检测,在20分钟内就能得出结果,而且不需要前往可能很远或很贵的实验室。这种用于诊断艾滋病毒的快速检测在肯尼亚已经使用了近20年。梅毒、疟疾和贫血也有类似的测试,尽管不太常用。我们已经(在不同的地点和不同的时间)成功地展示了以下情况:第一,可以与社区卫生工作者合作,改善将孕妇转介到卫生机构接受初级保健服务的情况;第二,综合护理点检测可以减少等待时间,并改善卫生机构最低级别的工作流程,分别提高ANC(产前护理)和检测的接受度。由于在相应的设施或社区中缺乏干预,这些单独的项目中的每一个都受到阻碍。在这项早期研究中,我们将首次将这两种经过验证的干预措施合并为一种综合方法,以改善产前护理,增加农村人口的接受程度。我们的目标是将怀孕期间接受所有四种疾病检测的女性人数至少增加50%。在这一早期阶段,我们将评估联合模式是否在现有卫生系统中起作用,以及它是否为使用它的社区成员和实施它的卫生工作者所接受。如果我们能够成功地将这两种方法结合成一个可行的有效干预措施(我们已经设定了目标来定义我们的意思),那么我们计划通过在肯尼亚西部进行的一项务实的整群随机对照试验(主要研究)来测试这种联合方法对妊娠结局的影响。我们的主要研究已经提交给欧洲联盟,并被欧洲联盟列入候选名单,我们希望它将在这一早期阶段研究的基础上获得成功的资助。
英文摘要
The uptake of antenatal care in early pregnancy is low, especially among rural populations and adolescents in Kenya. All pregnant women should be tested for common conditions that can cause harm to the mother or the baby so that these can be diagnosed and treated as early as possible in the pregnancy, ideally before 20 weeks of pregnancy. Kenyan guidelines recommend testing for HIV, syphilis, malaria (if they have fever) and anaemia. In practice, only HIV testing is done consistently and even this may be done late (and sometimes women who test positive may not get treatment in time). The other tests are very often missed altogether as women from rural areas cannot afford the time and money to go to laboratories at distant facilities and are put off attending antenatal care at lower facilities (like dispensaries) due to poor quality of services. All of these issues combined can lead to poor pregnancy outcomes for mothers and their newborns, especially among these vulnerable populations. Low cost technology that does not require trained laboratory personnel is available to do rapid testing at the point-of-care, giving a result in 20 minutes and overcoming the need to travel to a laboratory that may be far away or expensive to get to. Such rapid tests for the diagnosis of HIV have been in use in Kenya for close to 20 years. Similar tests for syphilis, malaria and anaemia are also available, though less commonly used. We have successfully shown (in separate locations and at separate times) the following: first that it is possible to work with community health workers to improve referral of pregnant women to health facilities for primary care services; and second, that integrated point of care testing can reduce waiting times and improve workflows at the lowest level of the health facility, improving uptake of ANC (Antenatal Care) and of testing respectively. Each of these separate projects was hampered by the absence of an intervention in the corresponding facility or community. In this early phase study, we will for the first time combine these two proven interventions into one combined approach to improve antenatal care, increasing its uptake among rural populations. Our ambition is to increase the number of women being tested for all four conditions in pregnancy by at least 50%. In this early phase we will assess if the combined model works within the existing health systems and if it is acceptable to the community members who utilised it and the health workers who implemented it. If we are successfully able to combine the two into a single feasible intervention that works (we have set targets to define what we mean by this) then we plan to go on to test the impact of this combined approach on pregnancy outcomes through a pragmatic cluster randomised controlled trial in western Kenya (the main study). Our main study has been submitted to, and shortlisted by, the European Union and we hope it will be successfully funded building on this early phase study.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1136/bmjgh-2020-002452
发表时间: 2021-03
期刊: BMJ global health
影响因子: 8.1
作者: [Kumar MB, Madan JJ, Auguste P, Taegtmeyer M, Otiso L, Ochieng CB, Muturi N, Mgamb E, Barasa E]
通讯作者: Barasa E
Additional file 1 of Antenatal testing for anaemia, HIV and syphilis in Indonesia - a health systems analysis of low coverage
印度尼西亚贫血、艾滋病毒和梅毒产前检测的附加文件 1 - 低覆盖率的卫生系统分析
DOI: 10.6084/m9.figshare.12399215
发表时间: 2020
期刊:
影响因子: --
作者: [C. Baker]
通讯作者: C. Baker
DOI: 10.3390/ijerph17186780
发表时间: 2020-09-17
期刊: International journal of environmental research and public health
影响因子: --
作者: [Madan J, Bruce Kumar M, Taegtmeyer M, Barasa E, Singh SP]
通讯作者: Singh SP
Recite: Building Research by Communities to Address Inequities through Expression
  • 批准号:
    AH/Z505341/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $275.45万
  • 财政年份:
    2024
  • 负责人:
    Miriam Taegtmeyer
  • 依托单位:
Building Research by Communities to address Inequities through Expression (ReCITE) Consortium
  • 批准号:
    AH/X005690/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $26.42万
  • 财政年份:
    2022
  • 负责人:
    Miriam Taegtmeyer
  • 依托单位:
HIV G.E.T (Gaming, Engaging and Testing) Project
  • 批准号:
    MR/N019202/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $45.28万
  • 财政年份:
    2016
  • 负责人:
    Miriam Taegtmeyer
  • 依托单位:
海外基金